Sanofi Still In Talks With Genzyme, Sees Lower 2011 Earnings

PARIS -(Dow Jones)- French drugs giant Sanofi-Aventis (SNY) Wednesday said talks with its takeover target U.S biotech Genzyme (GENZ) are ongoing, further extending months of suspense surrounding the deal as it forecast an earnings decline this year of between 5%-10%.